Test hydrogen gas for children needing emergency heart resuscitation
Part of Heart & circulation clinical trials.
This early safety study tests whether “hydrogen” can be given to children during emergency heart resuscitation that isn’t improving with standard efforts. It’s meant to see if the treatment is safe and feasible for a very specific, life-threatening situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be in a pediatric (newborn to 18 years) care setting, usually a cardiac ICU, at a participating hospital
- Have a heart problem such as congenital heart disease, myocarditis, an abnormal heart rhythm, or heart transplant rejection
- Be in a prolonged cardiac arrest (no effective heartbeat) lasting more than 5 minutes and still receiving CPR
- Your care team must decide to use ECPR because there are no other good options left
- Start the study treatment within 6 hours of the decision to use ECPR
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a targeted approach to manage oxygen levels in the brain for patients who received ECMO (a machine that does the heart and lung work) after a cardiac arrest that did not respond to standard CPR. The goal is to improve brain recovery and outcomes.
This trial tests whether using a machine to pump blood and oxygen (ECPR) right after a witnessed cardiac arrest with a shockable rhythm can improve survival. You might be eligible if you had a witnessed arrest, got bystander CPR, and your first rhythm was shockable, as long as the emergency team can reach the hospital in 30 minutes.
This trial is a registry that collects information about children (under 18) who have congenital heart problems and need resuscitation with chest compressions. It helps doctors understand these emergencies and may improve future care for similar patients.
This trial is studying the blood biomarkers and platelet characteristics in patients who receive CPR and are then placed on a heart-lung bypass machine (ECPR). It aims to understand how these biological markers relate to patient outcomes.
This study tests a specific heart-lung machine called Cardiohelp to help children with severe heart failure. It looks at how well the machine works and whether a blood thinner (either heparin or bivalirudin) is safer and more effective.
This study tests emergency treatments for people who have had a cardiac arrest (heart stops beating) outside the hospital. It looks at two groups: people whose hearts stop despite CPR efforts, and people whose hearts have restarted. The goal is to see if these treatments can help patients survive and recover better.
Hear when a new Cardiac Arrest trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.